BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29153851)

  • 1. APOBEC Enzymes as Targets for Virus and Cancer Therapy.
    Olson ME; Harris RS; Harki DA
    Cell Chem Biol; 2018 Jan; 25(1):36-49. PubMed ID: 29153851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
    Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
    Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research methods of anti-HIV-1 inhibitors targeting at Vif-APOBEC3G axis].
    Qiao X; Zhang W; Li Z; Zeng Y
    Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(6):806-9. PubMed ID: 21710755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
    Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
    Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
    Granadillo Rodríguez M; Flath B; Chelico L
    Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.
    Siriwardena SU; Chen K; Bhagwat AS
    Chem Rev; 2016 Oct; 116(20):12688-12710. PubMed ID: 27585283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interplay between HIV-1 and APOBEC].
    Sato K; Koyanagi Y
    Seikagaku; 2016; 88(5):569-75. PubMed ID: 29624319
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
    Mehle A; Wilson H; Zhang C; Brazier AJ; McPike M; Pery E; Gabuzda D
    J Virol; 2007 Dec; 81(23):13235-41. PubMed ID: 17898068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
    Romani B; Engelbrecht S; Glashoff RH
    Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
    Ito F; Fu Y; Kao SA; Yang H; Chen XS
    J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.
    Uriu K; Kosugi Y; Ito J; Sato K
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis.
    Anderson BD; Harris RS
    Sci Adv; 2015 Sep; 1(8):e1500296. PubMed ID: 26601257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
    Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
    J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
    Bishop KN; Holmes RK; Sheehy AM; Davidson NO; Cho SJ; Malim MH
    Curr Biol; 2004 Aug; 14(15):1392-6. PubMed ID: 15296758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
    Franca R; Spadari S; Maga G
    Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
    Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.